Form 4 for ACHV ACHIEVE LIFE SCIENCES, INC.
Accepted 2023-06-01 00:00:00 ET · period of report 2023-05-30 · accession 0001209191-23-033392 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-06-01 | 2023-05-30 | ACHV | Bencich John | CEO, Dir | P - Purchase | $5.50 | +5,000 | 66.7K | +8% | +$27.5K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-05-30 | P | A | 5,000 | $5.50 | 66,730 | D | — | — | (F1) The shares reported on this Form 4 were purchased in a registered direct offering at a price of $5.50 per share, for an aggregate purchase price of $27,500, pursuant to a Securities Purchase Agreement dated May 25, 2023. |